NCT05461170Phase 2Active not recruiting

SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.

Study sponsor: Vir Biotechnology, Inc. · VIR

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2031-11Estimated
Enrollment · participants95Actual
Source updated2026-06-26Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Aug 2029. After: Nov 2031.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview